Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Skinvisible (SKVI) EBT (2016 - 2025)

Skinvisible's EBT history spans 16 years, with the latest figure at -$250245.0 for Q3 2025.

  • For Q3 2025, EBT rose 14.51% year-over-year to -$250245.0; the TTM value through Sep 2025 reached -$1.2 million, up 1.53%, while the annual FY2024 figure was -$1.3 million, 47.04% up from the prior year.
  • EBT for Q3 2025 was -$250245.0 at Skinvisible, up from -$278957.0 in the prior quarter.
  • Across five years, EBT topped out at -$148564.0 in Q2 2021 and bottomed at -$1.5 million in Q1 2023.
  • The 5-year median for EBT is -$292726.0 (2024), against an average of -$361738.1.
  • The largest annual shift saw EBT tumbled 309.64% in 2023 before it surged 80.85% in 2024.
  • A 5-year view of EBT shows it stood at -$179296.0 in 2021, then plummeted by 128.05% to -$408893.0 in 2022, then grew by 25.58% to -$304295.0 in 2023, then decreased by 20.74% to -$367406.0 in 2024, then soared by 31.89% to -$250245.0 in 2025.
  • Per Business Quant, the three most recent readings for SKVI's EBT are -$250245.0 (Q3 2025), -$278957.0 (Q2 2025), and -$281005.0 (Q1 2025).